M. Everly

发表

HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation

A. Israni, B. Kasiske, M. Goodman, 2016, Transplantation.

β-Blocker Underuse in Secondary Prevention of Myocardial Infarction

P. Heaton, R. Cluxton, M. Everly, 2004, The Annals of pharmacotherapy.

Transplantation: Posttransplant Lymphoproliferative Disorder

R. Bloom, J. Trofe, D. Tsai, 2007, The Annals of pharmacotherapy.

Management of patients with a failed kidney transplant: Dialysis reinitiation, immunosuppression weaning, and transplantectomy.

P. Pham, M. Everly, P. Pham, 2015, World journal of nephrology.

Racial differences in incident de novo donor‐specific anti‐HLA antibody among primary renal allograft recipients: results from a single center cohort study

C. Haisch, A. Maldonado, P. Bolin, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Impact of the presence and duration of donor-specific antibodies on renal function.

P. Terasaki, J. Hoshino, M. Everly, 2014, Transplantation proceedings.

The Value of Protocol Biopsies to Identify Patients With De Novo Donor‐Specific Antibody at High Risk for Allograft Loss

M. Stegall, F. Cosio, D. Dadhania, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Personalized prediction of delayed graft function for recipients of deceased donor kidney transplants with machine learning

J. Beaumont, M. Everly, V. Jucaud, 2020, Scientific Reports.

Trajectories of health‐related quality of life among renal transplant patients associated with graft failure and symptom distress: Analysis of the BENEFIT and BENEFIT‐EXT trials

J. Beaumont, E. Alemao, M. Everly, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of De Novo Donor-specific Alloantibody in Primary Renal Allografts

M. Everly, 2017 .

Abrogation of Anti-HLA Antibodies via Proteasome Inhibition

P. Terasaki, H. Trivedi, A. Vanikar, 2009, Transplantation.

Monitoring and treating posttransplant human leukocyte antigen antibodies.

P. Terasaki, M. Everly, 2009, Human immunology.

Long‐term outcomes of eculizumab‐treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor‐specific antibodies

Byron H. Smith, M. Stegall, L. Cornell, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The clinical impact of humoral immunity in pediatric renal transplantation.

M. Sarwal, E. Kamil, T. Sigdel, 2013, Journal of the American Society of Nephrology : JASN.

The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes

C. Haisch, P. Terasaki, P. Bolin, 2013, Transplantation.

Model of Chronic Allograft Injury in Alloantibody Positive Renal Transplant Patients

M. Everly, W. O. Blvd, 2015 .

Onset and progression of de novo donor‐specific anti‐human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction

C. Haisch, A. Maldonado, P. Terasaki, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

The state of therapy for removal of alloantibody producing plasma cells in transplantation.

P. Terasaki, M. Everly, 2012, Seminars in immunology.

Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome Inhibition

P. Terasaki, H. Trivedi, M. Everly, 2010, Transplantation.

Antibody‐mediated rejection despite inhibition of terminal complement

M. Stegall, P. Dean, L. Cornell, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Durability of Antibody Removal Following Proteasome Inhibitor-Based Therapy

P. Terasaki, H. Trivedi, M. Everly, 2012, Transplantation.

Role of proteasome inhibition in sensitized transplant candidates.

P. Terasaki, M. Everly, J. Everly, 2011, Chinese medical journal.

Using Donor-Specific Antibodies to Monitor the Need for Immunosuppression

S. Greenland, P. Terasaki, J. Hoshino, 2012, Transplantation.

Factors at de novo donor‐specific antibody initial detection associated with allograft loss: a multicenter study

Byron H. Smith, M. Stegall, V. Sharma, 2019, Transplant international : official journal of the European Society for Organ Transplantation.

Antibiotic pretreatment alleviates liver transplant damage in mice and humans.

R. Busuttil, J. Kupiec-Weglinski, S. Uemoto, 2019, The Journal of clinical investigation.

The UNOS Renal Transplant Registry: Review of the Last Decade.

M. Everly, E. Huang, S. Bunnapradist, 2014, Clinical transplants.

Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.

E. Reed, J. Kobashigawa, J. Patel, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

COMPARISON OF IMMUNOSUPPRESSION RELATED TOXICITIES AND COMPLICATIONS IN OCULAR SURFACE TRANSPLANT AND RENAL TRANSPLANT RECIPIENTS: IMPLICATIONS FOR COMPOSITE TISSUE TRANSPLANTATION: 32

R. Alloway, E. Woodle, E. Holland, 2008 .

Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

R. Alloway, E. Woodle, L. Arend, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.

Jianghua Chen, P. Terasaki, M. Everly, 2013, Clinical biochemistry.

The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement

M. Stegall, A. Gaber, K. Romero, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

C. Haisch, P. Terasaki, P. Bolin, 2013, Transplantation.

Prevalence and Impact of De Novo Donor‐Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients

S. Feng, A. Shaked, J. Levitsky, 2019, Hepatology.

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

R. Alloway, E. Woodle, L. Arend, 2008, Transplantation.

Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry.

M. Everly, E. Cheng, 2014, Clinical transplants.

Clonal deletion using total lymphoid irradiation with no maintenance immunosuppression in renal allograft recipients.

P. Terasaki, H. Trivedi, A. Vanikar, 2009, Clinical transplants.

Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy.

K. Budde, N. Lachmann, P. Terasaki, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss

P. Terasaki, M. Everly, Lan Zhu, 2009, Transplantation.

Incidence and impact of anti‐HLA‐DP antibodies in renal transplantation

C. Haisch, P. Bolin, M. Everly, 2016, Clinical transplantation.

Changes in IgG subclasses of donor specific anti-HLA antibodies following bortezomib-based therapy for antibody mediated rejection.

V. Sharma, D. Dadhania, P. Putheti, 2012, Clinical transplants.

Comparison of de novo IgM and IgG anti‐HLA DSAs between belatacept‐ and calcineurin‐treated patients: An analysis of the BENEFIT and BENEFIT‐EXT trial cohorts

R. Bray, H. Gebel, R. Townsend, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Is ABO-Compatible but Non-Identical Intestinal Transplant Comparable to ABO-Identical Transplant? An Analysis of the UNOS Registry

Junchao Cai, Guosheng S. Wu, M. Everly, 2015 .

Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection.

Junchao Cai, N. Lachmann, P. Terasaki, 2016, Experimental and molecular pathology.

Detailed examination of HLA antibody development on renal allograft failure and function.

P. Terasaki, M. Everly, Lan Zhu, 2008, Clinical transplants.

Cardiac transplantation in the United States: an analysis of the UNOS registry.

M. Everly, 2008, Clinical transplants.

Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients

R. Busuttil, E. Marcus, P. Terasaki, 2017, Transplantation.

Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine.

Junchao Cai, Guosheng S. Wu, M. Everly, 2014, Clinical transplants.

A summary of bortezomib use in transplantation across 29 centers.

M. Everly, 2009, Clinical transplants.

Elimination of post-transplant donor-specific HLA antibodies with bortezomib.

P. Terasaki, A. Vanikar, S. Dave, 2008, Clinical transplants.

Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.

M. Everly, 2011, Clinical transplants.

Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes

Mario Scalamogna, Francesca Poli, Marina Scavini, 2013, Diabetes.

Beyond Histology: Lowering Human Leukocyte Antigen Antibody to Improve Renal Allograft Survival in Acute Rejection

C. Haisch, P. Terasaki, P. Catrou, 2010, Transplantation.

Proteasome inhibition reduces donor-specific antibody levels.

R. Alloway, E. Woodle, L. Arend, 2009, Transplantation proceedings.

Pancreas transplantation in the United States: an analysis of the UNOS registry.

M. Everly, 2009, Clinical transplants.

Pediatric intestinal transplantation: Analysis of the intestinal transplant registry

J. Beaumont, G. Mazariegos, R. Venick, 2019, Pediatric transplantation.

Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients.

P. Terasaki, H. Trivedi, A. Vanikar, 2010, Transplantation.

The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection

M. Hamdorf, M. Everly, S. Kawakita, 2017, Journal of immunology research.

Heart transplantation in the United States from 1998 to 2008.

M. Ravindranath, M. Everly, 2009, Clinical transplants.

Impact of Tocilizumab (Anti–IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection

S. Jordan, Hao Zhang, Xiaohai Zhang, 2020, Transplantation.

Impact of IgM and IgG3 Anti-HLA Alloantibodies in Primary Renal Allograft Recipients

C. Haisch, A. Maldonado, P. Terasaki, 2014, Transplantation.

Changes in Successive Measures of De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibodies Intensity and The Development of Allograft Dysfunction

C. Haisch, P. Terasaki, P. Bolin, 2014, Transplantation.

Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score’s Ability to Determine Long-term Outcome

G. Klintmalm, A. Demetris, L. Jennings, 2017, Transplantation.

OR17 Epitope load does not predict development of de novo antibodies to HLA in patients with BK virus nephropathy

V. Sharma, M. Suthanthiran, D. Dadhania, 2018, Human Immunology.

Use of bortezomib as adjunctive therapy for densensitization in combined heart and kidney transplantation--a case report.

J. Kobashigawa, J. Patel, M. Kittleson, 2009, Clinical transplants.

Nature and Clonality of the Fluoresceinated Secondary Antibody in Luminex Multiplex Bead Assays Are Critical Factors for Reliable Monitoring of Serum HLA Antibody Levels in Patients for Donor Organ Selection, Desensitization Therapy, and Assessment of the Risk for Graft Loss

Junchao Cai, P. Terasaki, A. Nguyen, 2017, The Journal of Immunology.

PROTEASOME INHIBITION EFFECTIVELY TREATS ACUTE CELLULAR REJECTION, ANTIBODY MEDIATED REJECTION, AND PROVIDES LONG-TERM REDUCTION OF DONOR SPECIFIC ANTIBODIES: 195

R. Alloway, E. Woodle, L. Arend, 2008 .

HLA Antibodies Developed in the First Year Post Transplant Are Predictive of Renal Allograft Failure.

P. Terasaki, M. Everly, Lan Zhu, 2009 .

Donor-specific HLA antibody response in clonal deletion.

P. Terasaki, A. Vanikar, S. Dave, 2008, Clinical transplants.

BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitization.

E. L. Luning Prak, M. Cancro, D. Allman, 2021, Transplant immunology.

The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation

L. Minasian, T. van Gelder, R. Alloway, 2021, Transplantation.

Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients

G. Klintmalm, R. Pfeiffer, E. Engels, 2018, Transplantation direct.

Trends and Characteristics in Early Glomerular Filtration Rate Decline After Posttransplantation Alloantibody Appearance

C. Haisch, P. Terasaki, P. Bolin, 2013, Transplantation.

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

R. Alloway, L. Arend, G. Mogilishetty, 2008, Transplantation.

Antibody‐mediated rejection despite inhibition of terminal complement

M. Stegall, P. Dean, L. Cornell, 2014, Transplant International.

The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes

C. Haisch, P. Terasaki, P. Bolin, 2013, Transplantation.

Using Donor-Specific Antibodies to Monitor the Need for Immunosuppression

S. Greenland, P. Terasaki, J. Hoshino, 2012, Transplantation.

The clinical impact of humoral immunity in pediatric renal transplantation.

M. Sarwal, E. Kamil, T. Sigdel, 2013, Journal of the American Society of Nephrology : JASN.

Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

R. Alloway, E. Woodle, L. Arend, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.